MS: Busting the Myths
February 29, 2024 | Advocacy, Treatments
Pharmac announced, in February, it was looking to extend funded access to Shingrix, the new vaccination for shingles, to immunocompromised people over 18 years old. However, the proposal listed specific treatments and conditions eligible. While we were pleased to see […]
February 29, 2024 | Treatments
In December 2023, Pharmac proposed to decline funding for inactive applications, this included an application to fund Sativex for MS spasticity. MSNZ has written to the Pharmac Board to ask that this application remain live and we be permitted to […]
February 29, 2024 | Advocacy
Multiple Sclerosis NZ is a proud member of the Neurological Alliance along with 19 other allied organisations. The Neurological Alliance of New Zealand (the Alliance) was established in 1999 to provide a forum for organisations representing a neurological disease to: […]
June 22, 2023 | Advocacy, Funding, Media, Progressive
Multiple Sclerosis New Zealand (MSNZ) is delighted to share that Pharmac have commenced consultation to fund Ocrelizumab for Primary Progressive MS. Currently, those with PPMS have no access to any disease modifying therapies. Ocrelizumab has been proven in trials to […]
August 8, 2022 | Funding, Grants, Life with MS, Scholarships
Last year I was the successful recipient of the Mastering Mountains Grant for people with FND and MS. My objective was to climb a 3,000m peak the Southern Alps. When I first submitted my application for the Grant I had […]